Skip to main content
Fig. 1 | Stem Cell Research & Therapy

Fig. 1

From: Infusion-related thrombogenesis by liver-derived mesenchymal stem cells controlled by anticoagulant drugs in 11 patients with liver-based metabolic disorders

Fig. 1

Monitoring of portal vein pressure before and after intraportal infusion of HepaStem in patients (n = 11). Portal vein pressure was monitored through a portal catheter before and every 15 min during and after the infusions until normalization. a Portal vein pressure is represented for each patient during 1, 2, or 3 days of HepaStem infusions. The horizontal dotted line is the maximum normal value. b 95% CI (confidence interval) whiskers representing portal vein pressure for all patients at different time points. Statistical analysis: Wilcoxon signed-rank test. The horizontal dotted line represents the mean before infusion. *p < 0.05; **p < 0.01; ***p < 0.001

Back to article page